Researchers at the University of Sydney are conducting a wide-ranging study concerning quality of life issues for medicinal cannabis patients.

Funded by Australian medicinal cannabis firm Little Green Pharma (LGP), the QUality of life Evaluation STudy (The QUEST Initiative) will delve into related patient outcomes and aims to recruit 2,100 patients by June this year.

The Australian Government is backing the study.

“The QUEST Initiative represents a significant Australian contribution to the global need for reliable, objective and clinically-relevant quality of life data for patients accessing medicinal cannabis treatments for a broad range of chronic conditions,” said Federal Minister for Health, Greg Hunt.

 

More at  https://hempgazette.com/news/quality-life-cannabis-hg1379/